Sign in

Teresa S. Weber

Chief Executive Officer, Board Member at biote
Board
Since March 2019
Age
70 years
Education
Holds an M.S. in Management from Purdue University and a B.S. in Economics from New College Florida.
Tenure
Has served as the Chief Executive Officer since March 2019 and held board roles since joining BTMD in June 2018, with the position as Board Member being updated in May 2022.

Also at biote

MEC
Mary Elizabeth Conlon
VP, Business Development, General Counsel, Corporate Secretary
RCP
Robert C. Peterson
Chief Financial Officer

About

Teresa S. Weber is a seasoned executive known for her significant leadership in the healthcare sector. With extensive experience in managing and growing organizations, she has played a key role in steering her companies through strategic transformations in a rapidly evolving industry.

In her role as Chief Executive Officer and Board Member at BTMD, she has leveraged her strategic vision and operational expertise to drive innovative initiatives and long-term growth. Her contributions have been central to setting the company’s direction and fostering strong governance practices.

Prior to her tenure at BTMD, she held critical leadership positions at Amen Clinics, Inc. and Mattioli Weber Consulting, where she gained valuable insights into healthcare management and consulting. Her career reflects a consistent record of achievements, demonstrating her capacity to lead diverse organizations towards success.

$BTMD Performance Under Teresa S. Weber

Past Roles

OrganizationRoleDate RangeDetails
BioTE Medical Chief Executive Officer March 2019 - May 2022 Held before joining BTMD.
BioTE Medical Board Member (Board of Managers) June 2018 - May 2022 Held before joining BTMD.
Amen Clinics, Inc. Chief Executive Officer January 2015 - March 2019 Outpatient healthcare clinic company.
Mattioli Weber Consulting Partner and Consultant Since June 2013 Marketing, service, and retail consulting firm.

Fixed Compensation

Data from  FY 2023
Component NameAmountPayment ScheduleAdditional Details
Base Salary$610,000 AnnualCompensation for services rendered as CEO of Biote

Performance Compensation

Data from  FY 2023

Non-Equity Incentive Plan Compensation

MetricDetails
ComponentCash-based Performance Bonus
Dollar Amount$457,125
Performance Metric2023 Corporate Goals Achievement
Evaluation Period2023
Actual Achievement75%
Calculation BasisPercentage of gross base salary
Vesting ScheduleNot applicable (cash-based)
Grant Date / Fair ValueNot applicable
Additional DetailsNo further details on thresholds, targets, weights, or caps were provided